Ranibizumab(Lucentis®))
NICE TA 155, TA 274, TA 283 and TA 298
-
Traffic LightRed
-
BNF11.8.2
-
Licensed IndicatorsChoroidal neovascularisation, Macular oedema, Macular degeneration
-
ReferenceAPC Dec 13
-
ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?